Ilyang Pharm (007570) — Long-term Investment Intensity

Latest as of December 2019: 0.8%

Ilyang Pharm (007570) has a Long-term Investment Intensity of 0.8% as of December 2019. Long-term investments of ₩3.36 Billion represent 0.8% of total assets of ₩437.46 Billion. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check Ilyang Pharm (007570) asset resilience to evaluate the company's liquid asset resilience ratio.

LT Investment Intensity

0.8%
LT Investments / Total Assets

Long-term Investments

₩3.36 Billion
KRW

Total Assets

₩437.46 Billion
KRW

Country

Korea
KO

Ilyang Pharm Long-term Investment Intensity (2013–2019)

This chart shows how Ilyang Pharm's Long-term Investment Intensity has evolved across 7 annual periods from 2013 to 2019. As of December 2019, the intensity stands at 0.8%, reflecting long-term investments of ₩3.36 Billion against total assets of ₩437.46 Billion KRW. For the complete balance sheet picture, see 007570 total asset value.

Annual Long-term Investment Intensity for Ilyang Pharm (2013–2019)

The table below presents the year-by-year Long-term Investment Intensity for Ilyang Pharm from 2013 to 2019, covering 7 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. Read Ilyang Pharm debt and liabilities for a breakdown of total debt and financial obligations.

Year LT Investment Intensity LT Investments (KRW) Total Assets Change (pp)
2019 0.8% ₩3.36 Billion ₩437.46 Billion ▼ -0.3 pp
2018 1.0% ₩4.47 Billion ₩432.25 Billion ▼ -0.1 pp
2017 1.2% ₩5.11 Billion ₩436.37 Billion ▲ +0.1 pp
2016 1.1% ₩4.56 Billion ₩431.26 Billion ▲ +0.2 pp
2015 0.9% ₩3.72 Billion ₩431.63 Billion ▲ +0.1 pp
2014 0.8% ₩3.44 Billion ₩430.83 Billion ▼ -2.1 pp
2013 2.9% ₩11.47 Billion ₩398.38 Billion
pp = percentage points